Literature DB >> 23273790

The diagnostic utility of MRI in spondyloarthritis.

Susanne J Pedersen1, Ulrich Weber, Mikkel Ostergaard.   

Abstract

The recently developed Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axial and peripheral spondyloarthritis (SpA) are the first criteria ever to include findings on magnetic resonance imaging (MRI) of the sacroiliac joints. Features indicating sacroiliac joint inflammation on MRI are weighted equally to structural changes on conventional radiography, and thus MRI has become an important tool for use in daily practice to evaluate patients with clinically suspected early spondyloarthritis. However, MRI can also detect structural changes such as erosions and fat infiltrations, and recent studies suggest that assessment of both inflammatory and structural changes of the sacroiliac joints may improve the diagnostic utility of MRI. The present article reviews the evidence for the use of sacroiliac joint and spinal MRI to assess patients with axial and peripheral SpA, focussing on controlled studies of patients with early SpA, which also included patients with mechanical back pain and healthy subjects, published within the last 5 years.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23273790     DOI: 10.1016/j.berh.2012.10.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  7 in total

1.  Musculoskeletal imaging of the inflammatory and degenerative joints: current status and perspectives.

Authors:  Fausto Salaffi; Marina Carotti; Antonio Barile
Journal:  Radiol Med       Date:  2019-02-27       Impact factor: 3.469

Review 2.  The changing clinical picture and epidemiology of spondyloarthritis.

Authors:  Astrid van Tubergen
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

3.  Andersson lesions of whole spine magnetic resonance imaging compared with plain radiography in ankylosing spondylitis.

Authors:  Seong-Kyu Kim; Kichul Shin; Yoonah Song; Seunghun Lee; Tae-Hwan Kim
Journal:  Rheumatol Int       Date:  2016-07-26       Impact factor: 2.631

Review 4.  Biological therapies for spondyloarthritis.

Authors:  Vincenzo Bruner; Mariangela Atteno; Angelo Spanò; Raffaele Scarpa; Rosario Peluso
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-06       Impact factor: 5.346

Review 5.  Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies.

Authors:  Francesco Caso; Luisa Costa; Antonio Del Puente; Matteo Nicola Dario Di Minno; Gelsy Lupoli; Raffaele Scarpa; Rosario Peluso
Journal:  Ther Adv Chronic Dis       Date:  2015-11       Impact factor: 5.091

6.  Evaluation of the performances of 'typical' imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study.

Authors:  Anna Molto; Laure Gossec; Marie-Martine Lefèvre-Colau; Violaine Foltz; Romain Beaufort; Jean-Denis Laredo; Pascal Richette; Philippe Dieude; Philippe Goupille; Antoine Feydy; Maxime Dougados
Journal:  RMD Open       Date:  2019-05-28

7.  Role of Physical Evaluation in the Early Identification of Axial Spondyloarthritis: A Research Proposal.

Authors:  Marcelo P Castro; Simon M Stebbings; Stephan Milosavljevic; Melanie D Bussey
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2015-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.